Literature DB >> 26860246

Commentary on Enns et al. (2016): Supervised injection facilities as a cost-effective intervention.

Nadia Fairbairn1, Evan Wood2,3.   

Abstract

Entities:  

Keywords:  Cost-effectiveness; HCV; HIV; harm reduction; injection drug use; supervised injection facilities

Mesh:

Year:  2016        PMID: 26860246      PMCID: PMC5279864          DOI: 10.1111/add.13242

Source DB:  PubMed          Journal:  Addiction        ISSN: 0965-2140            Impact factor:   6.526


× No keyword cloud information.
  15 in total

1.  Changes in public order after the opening of a medically supervised safer injecting facility for illicit injection drug users.

Authors:  Evan Wood; Thomas Kerr; Will Small; Kathy Li; David C Marsh; Julio S G Montaner; Mark W Tyndall
Journal:  CMAJ       Date:  2004-09-28       Impact factor: 8.262

Review 2.  Oral substitution treatment of injecting opioid users for prevention of HIV infection.

Authors:  Linda Gowing; Michael F Farrell; Reinhard Bornemann; Lynn E Sullivan; Robert Ali
Journal:  Cochrane Database Syst Rev       Date:  2011-08-10

3.  Facilitating entry into drug treatment among injection drug users referred from a needle exchange program: Results from a community-based behavioral intervention trial.

Authors:  Steffanie A Strathdee; Erin P Ricketts; Steven Huettner; Lee Cornelius; David Bishai; Jennifer R Havens; Peter Beilenson; Charles Rapp; Jacqueline J Lloyd; Carl A Latkin
Journal:  Drug Alcohol Depend       Date:  2005-12-20       Impact factor: 4.492

4.  Attendance at supervised injecting facilities and use of detoxification services.

Authors:  Evan Wood; Mark W Tyndall; Ruth Zhang; Jo-Anne Stoltz; Calvin Lai; Julio S G Montaner; Thomas Kerr
Journal:  N Engl J Med       Date:  2006-06-08       Impact factor: 91.245

5.  Reduction in overdose mortality after the opening of North America's first medically supervised safer injecting facility: a retrospective population-based study.

Authors:  Brandon D L Marshall; M-J Milloy; Evan Wood; Julio S G Montaner; Thomas Kerr
Journal:  Lancet       Date:  2011-04-15       Impact factor: 79.321

6.  Rate of detoxification service use and its impact among a cohort of supervised injecting facility users.

Authors:  Evan Wood; Mark W Tyndall; Ruth Zhang; Julio S G Montaner; Thomas Kerr
Journal:  Addiction       Date:  2007-06       Impact factor: 6.526

7.  A cost-benefit and cost-effectiveness analysis of Vancouver's supervised injection facility.

Authors:  Martin A Andresen; Neil Boyd
Journal:  Int J Drug Policy       Date:  2009-05-06

8.  Emerging role of supervised injecting facilities in human immunodeficiency virus prevention.

Authors:  M-J Milloy; Evan Wood
Journal:  Addiction       Date:  2009-04       Impact factor: 6.526

9.  How many HIV infections are prevented by Vancouver Canada's supervised injection facility?

Authors:  Steven D Pinkerton
Journal:  Int J Drug Policy       Date:  2011-03-29

10.  HIV and risk environment for injecting drug users: the past, present, and future.

Authors:  Steffanie A Strathdee; Timothy B Hallett; Natalia Bobrova; Tim Rhodes; Robert Booth; Reychad Abdool; Catherine A Hankins
Journal:  Lancet       Date:  2010-07-24       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.